Results of Ventricular Septal Myectomy and Hypertrophic Cardiomyopathy (from Nationwide Inpatient Sample [1998

Results of Ventricular Septal Myectomy and Hypertrophic Cardiomyopathy (from Nationwide Inpatient Sample [1998–2010])

Published:2014-11 Issue:9 Volume:114 Page:1390-1395
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Panaich Sidakpal S.,Badheka Apurva O.,Chothani Ankit,Mehta Kathan,Patel Nileshkumar J.,Deshmukh Abhishek,Singh Vikas,Savani Ghanshyambhai T.,Arora Shilpkumar,Patel Nilay,Bhalara Vipulkumar,Grover Peeyush,Shah Neeraj,Elder Mahir,Mohamad Tamam,Kaki Amir,Kondur Ashok,Brown Michael,Grines Cindy,Schreiber Theodore

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference24 articles.

1. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction;Maron;Circulation,2006

2. The surgical management of obstructive cardiomyopathy;Cleland;J Cardiovasc Surg (Torino),1963

3. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy

4. Surgical myectomy for hypertrophic obstructive cardiomyopathy: the cut that heals;Williams;Circulation,2013

5. Comparison of surgical septal myectomy to medical therapy alone in patients with hypertrophic cardiomyopathy and syncope;Orme;Am J Cardiol,2013

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitral Leaflet Shortening as an Ancillary Procedure in Obstructive Hypertrophic Cardiomyopathy;The Annals of Thoracic Surgery;2024-08

2. Novel Cardiac Myosin Inhibitor Therapy for Hypertrophic Cardiomyopathy in Adults: A Contemporary Review;American Journal of Cardiovascular Drugs;2024-07-19

3. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines;Circulation;2024-06-04

4. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy;Journal of the American College of Cardiology;2024-06

5. Real-world experience with mavacamten in obstructive hypertrophic cardiomyopathy: Observations from a tertiary care center;Progress in Cardiovascular Diseases;2024-02